课题基金 / 基金详情

Genesis of Liver Carcinomas with Oval Cell Traits

Genesis of Liver Carcinomas with Oval Cell Traits
具有卵圆细胞特征的肝癌的起源
批准号:
7483693
负责人:
Douglas Carter Hixson
金额:
$33.86万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2002
资助国家:
美国
项目状态:
已结题
起止时间:
2002-04-01 至 2012-05-31

项目摘要

项目成果

Douglas Carter Hixson的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):尽管有令人信服的证据表明成人肝脏中存在双能祖细胞,但这些祖细胞在肝癌发生中的作用仍然是一个争论的主题。建立在我们过去的经验,胆管细胞和卵圆细胞,双能胆汁祖细胞激活的大多数肝癌,我们继续努力,以确定和表征双能祖细胞存在于胆道树,并确定其在肝和胆管癌的作用。在过去的4年中,我们的研究胆管细胞标志物阳性(CMP),双能,胎儿肝上皮细胞(FLEC)已经产生了新的单克隆抗体为基础的计划,分离双能CMP-FLEC。将来自二肽基肽酶IV(DPPIV)阳性大鼠的CMP-FLEC分离物移植到用反曲马新/部分肝切除术(R/PH)处理的DPPIV缺陷宿主大鼠中的结果导致意外的发现,CMP-FLEC在R/PH处理的成人肝脏中具有比胎儿成肝细胞和其他非实质细胞类型高得多的生长能力。在目前的提案中,分离方案开发的双能CMP-FLEC将适用于分离表型等效的CMP-肝上皮细胞(CMP-LEC)从新生和成年大鼠肝脏。我们假设这些胎儿样CMP-FLEC将具有类似于卵圆细胞的肝细胞分化能力,并在体外自发转化和体内进展为HCC后保留这种能力。在具体目标1中,我们将采用一种快速移植模型,用丝裂霉素C(mitoC/PH)替代倒霉碱,以检验以下假设:胆管细胞标志物OC. 4(出生后2岁首次观察到的标志物)的表达鉴定出肝细胞分化能力大大降低的成熟CMP-LEC。在具体目标2中,我们将检验自发转化的CMP-LEC和卵圆细胞而不是BDEC在mitoC/PH处理的大鼠中将经历不完全的肝细胞分化并进展为CMP-HCC的假设。CMP-LEC的自发转化将通过在塑料和/或软琼脂上选择、用ErbB 2转染或原位暴露于致癌物来加速。在特定目标3中,将使用基因组学和蛋白质组学方法来绘制BDEC、CMP-LEC和卵圆细胞自发转化期间有效的信号传导途径,这些信号传导途径促进存活并与ErbB 2合作以赋予锚定独立/侵入性生长。具体目标4将继续BD. 1的表征,BD. 1是一种由胆管细胞而非卵圆细胞表达的170 kDa蛋白,与CLIP 170(一种微管相关蛋白)形成稳定的复合物。我们将测试的假设,BD.1的损失改变微管/动粒动力学的方式,促进非整倍体。这些研究将为双能祖细胞在肝癌中的作用提供新的见解。
英文摘要
DESCRIPTION (provided by applicant): Although there is compelling evidence for the presence of bipotent progenitor cells in the adult liver, the role of these progenitors s in hepatocarcinogenesis is still a subject of debate. Building on our past experience with cholangiocytes and oval cells, bipotent biliary progenitors activated by most hepatocarcinogens, we have continued with our efforts to identify and characterize bipotent progenitors present in the biliary tree and to ascertain their role in hepato-and cholangio-carcinogenesis. Over the past 4 years, our studies of cholangiocyte marker positive (CMP), bipotent, fetal liver epithelial cells (FLEC) have yielded novel monoclonal antibody based schemes for isolating bipotent CMP-FLEC. Results from transplantation of CMP-FLEC isolates from dipeptidyl peptidase IV (DPPIV) positive rats into DPPIV deficient host rats treated with retrorsine/partial hepatectomy (R/PH) led to the unexpected finding that CMP-FLEC possesses a much higher capacity for growth in the R/PH treated adult liver than fetal hepatoblasts and other nonparenchymal cell types. In the current proposal, isolation schemes developed for bipotent CMP-FLEC will be applied to the isolation of phenotypically equivalent CMP-liver epithelial cells (CMP-LEC) from newborn and adult rat liver. We hypothesize that these fetal-like CMP-FLEC will possess a capacity for hepatocytic differentiation similar to oval cells and will retain this capacity following spontaneous transformation in vitro and progression to HCC in vivo. In Specific Aim 1, we will employ a rapid transplantation model that replaces retrorsine with mitomycin C (mitoC/PH) to test the hypothesis that the expression of the cholangiocyte marker OC.4, a marker first seen at 2 after birth, identifies mature CMP-LEC that have a greatly diminished capacity for hepatocytic differentiation. In Specific Aim 2, we will test the hypothesis that spontaneously transformed CMP-LEC and oval cells but not BDEC will undergo incomplete hepatocytic differentiation in mitoC/PH treated rats and progress to CMP-HCC. Spontaneous transformation of CMP-LEC will be accelerated by selection on plastic and/or soft agar, transfection with ErbB2 or exposure to carcinogen in situ. In Specific Aim 3, genomic and proteomic methodologies will be used to map the signaling pathways operative during the spontaneous transformation of BDEC, CMP-LEC and oval cells that promote survival and cooperate with ErbB2 to confer anchorage independent/invasive growth. Specific Aim 4 will continue with the characterization of BD.1, a 170 kDa protein expressed by cholangiocytes but not oval cells that forms stable complexes with CLIP170, a microtubule associated protein. We will test the hypothesis that loss of BD.1 alters microtubule/kinetochore dynamics in a manner that promotes aneuploidy. The proposed studies will provide new insights into the role of bipotent progenitors in liver cancer.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
COBRE: RIH:CORE A: ADMINISTRATION & CAREER DVMT
  • 批准号:
    8359710
  • 项目类别:
  • 资助金额:
    $44.52万
  • 财政年份:
    2011
  • 负责人:
    Douglas Carter Hixson
  • 依托单位:
COBRE: RIH:CORE A: ADMINISTRATION & CAREER DVMT
  • 批准号:
    8167900
  • 项目类别:
  • 资助金额:
    $37.33万
  • 财政年份:
    2010
  • 负责人:
    Douglas Carter Hixson
  • 依托单位:
COBRE: RIH:CORE A: ADMINISTRATION & CAREER DVMT
  • 批准号:
    7960504
  • 项目类别:
  • 资助金额:
    $46.9万
  • 财政年份:
    2009
  • 负责人:
    Douglas Carter Hixson
  • 依托单位:
COBRE: RIH:CORE A: ADMINISTRATION & CAREER DVMT
  • 批准号:
    7381870
  • 项目类别:
  • 资助金额:
    $40.13万
  • 财政年份:
    2006
  • 负责人:
    Douglas Carter Hixson
  • 依托单位:
海外基金